Cargando…
The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges
Recurrent pericarditis is a common complication of acute pericarditis (15–30%) for which, in most cases, no underlying etiology is found [idiopathic recurrent pericarditis (IRP)]. IRP is currently viewed as an autoinflammatory disease with characteristic recurrent episodes of sterile inflammation. A...
Autores principales: | Lazaros, George, Antonatou, Katerina, Vassilopoulos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466978/ https://www.ncbi.nlm.nih.gov/pubmed/28660191 http://dx.doi.org/10.3389/fmed.2017.00078 |
Ejemplares similares
-
Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences
por: Perrone, Antonio, et al.
Publicado: (2019) -
Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2020) -
Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
por: Roubille, François, et al.
Publicado: (2022) -
Tuberculous Pericarditis: A Complex Puzzle to Put Together
por: Lazaros, George, et al.
Publicado: (2015) -
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021)